Submission for OMB Review; Comment Request, 37600-37601 [2016-13682]
Download as PDF
<![CDATA[
37600
Federal Register / Vol. 81, No. 112 / Friday, June 10, 2016 / Notices
submitter can resubmit the request with
appropriate supporting documentation.
• Scenario 4: When the HHA
provides the treatment to the beneficiary
and submits the claim to the MAC for
payment without submitting a pre-claim
review request, the home health claim
will be stopped for prepayment review
and documentation will be requested. If
the claim is determined to be not
medically necessary or not sufficiently
documented, the claim will be denied
and all current policies and procedures
regarding liability for payment will
apply. The HHA, the beneficiary, or
both can appeal the claim denial if they
believe the claim was payable. If the
claim is determined to be payable on
appeal, it will be paid. After the first 3
months of the demonstration, we will
reduce payment by 25 percent for
claims that after such prepayment
review are deemed payable but did not
first receive a pre-claim review decision.
This payment reduction is not subject to
appeal. After a claim is submitted,
processed, and denied, appeal rights for
the claim denial would become
available in accordance with 42 CFR
part 405, subpart I. The 25-percent
payment reduction cannot be charged to
the beneficiary. The beneficiary would
not be liable for more than he or she
would otherwise be if the demonstration
were not in place.
Additional information is available on
the CMS’ Web site at https://
www.cms.gov/Research-Statistics-Dataand-Systems/Monitoring-Programs/
Medicare-FFS-Compliance-Programs/
Overview.html.
III. Collection of Information
Requirements
asabaliauskas on DSK3SPTVN1PROD with NOTICES
We announced and solicited
comments for the information collection
requirements associated with the
Medicare Prior Authorization of Home
Health Services Demonstration in a 60day Federal Register notice that
published on February 5, 2016 (81 FR
6275). The information collection
requirements do not take effect until
they are approved by OMB and issued
a valid OMB control number.
Dated: May 26, 2016.
Andrew M. Slavitt,
Acting Administrator, Centers for Medicare
& Medicaid Services.
[FR Doc. 2016–13755 Filed 6–8–16; 4:15 pm]
BILLING CODE 4120–01–P
VerDate Sep<11>2014
19:02 Jun 09, 2016
Jkt 238001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
[CFDA Number: 93.092]
Announcing the Intent To Award
Single-Source Expansion Supplement
Grants to Two Personal Responsibility
Education Program Innovative
Strategies (PREIS) Grantees
Family and Youth Services
Bureau, ACYF, ACF.
ACTION: This notice announces the
intent to award single-source expansion
supplement grants under the Personal
Responsibility Education Program
Innovative Strategies (PREIS) program to
Children’s Hospital of Los Angeles in
Los Angeles, CA and Education
Development Center, Inc. in Newton,
MA.
AGENCY:
The Administration for
Children and Families (ACF),
Administration on Children, Youth and
Families (ACYF), Family and Youth
Services Bureau (FYSB), Adolescent
Pregnancy Prevention Program,
announces its intent to award a singlesource expansion supplement grant of
up to $151,265 to Children’s Hospital of
Los Angeles and up to $55, 917.20 to
Education Development Center, Inc.
DATES: The period of support for the
single-source expansion supplements is
September 30, 2015, through September
29, 2016.
FOR FURTHER INFORMATION CONTACT:
LeBretia White, Program Manager,
Adolescent Pregnancy Prevention
Program, Division of Adolescent
Development and Support, Family and
Youth Services Bureau, 330 C Street
SW., Washington, DC 20201. Telephone:
202–205–9605; Email: LeBretia.White@
acf.hhs.gov.
SUPPLEMENTARY INFORMATION: Children’s
Hospital of Los Angeles is funded under
the Personal Responsibility Education
Program Innovative Strategies (PREIS)
program to adapt an existing evidencebased pregnancy prevention program for
pregnant and parenting teens and
rigorously evaluate the program for its
impact on reducing repeat pregnancy.
The supplemental award will be used to
review, code, and analyze digital
recordings, employ intensive tracking
and follow up efforts with participants
to administer the 36-month follow-up
survey, conduct additional advanced
analyses, develop manuscripts and
briefs based on additional analyses, and
disseminate study findings.
Education Development Center, Inc. is
funded under the Personal
SUMMARY:
PO 00000
Frm 00035
Fmt 4703
Sfmt 4703
Responsibility Education Program
Innovative Strategies (PREIS) program to
implement a parent education program
for Latino youth (Salud y Exito/Health
and Success) and to rigorously evaluate
the intervention to determine impact on
reducing sexual risk-taking behavior.
The supplement award will be used to
augment dissemination efforts for the
intervention by developing a social
media campaign to promote the
intervention Web site and to analyze
social media data to determine the
campaign’s reach.
Statutory Authority: The statutory
authority for the award is Sec. 513 of the
Social Security Act (42 U.S.C. 713). Sec. 2953
of the Patient Protection and Affordable Care
Act of 2010 (Pub. L. 111–148) established
PREP and funded it for FY 2010 through
2014. Sec. 206 of the Protecting Access to
Medicare Act of 2014 (Pub. L. 113–93)
extended that funding through FY 2015. Sec.
215 of the Medicare Access and CHIP
Reauthorization Act of 2015 (Pub. L. 114–10)
extended funding through FY 2017.
Christopher Beach,
Senior Grants Policy Specialist, Division of
Grants Policy, Office of Administration,
Administration for Children and Families.
[FR Doc. 2016–13698 Filed 6–9–16; 8:45 am]
BILLING CODE 8414–37–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Submission for OMB Review;
Comment Request
Title: National Survey of Child and
Adolescent Well-Being-Third Cohort
(NSCAW III): Agency Recruitment.
OMB No.: 0970–0202.
Description: The Administration for
Children and Families (ACF) within the
U.S. Department of Health and Human
Services (HHS) intends to collect data
on a third cohort of children and
families for the National Survey of Child
and Adolescent Well-Being (NSCAW).
NSCAW is the only source of nationally
representative, longitudinal, firsthand
information about the functioning and
well-being, service needs, and service
utilization of children and families who
come to the attention of the child
welfare system. The first two cohorts of
NSCAW were collected beginning in
1999 and 2008 and studied children
who had been the subject of
investigation by Child Protective
Services. Children were sampled from
child welfare agencies nationwide.
The proposed data collection plan for
the third cohort of NSCAW includes
two phases: Phase 1 includes child
E:\FR\FM\10JNN1.SGM
10JNN1
37601
Federal Register / Vol. 81, No. 112 / Friday, June 10, 2016 / Notices
welfare agency recruitment and
collection of files for sampling children,
and Phase 2 includes baseline data
collection and an 18-month follow-up
data collection. The current data
collection plan calls for selecting a new
cohort of 4,565 children and families
and repeating similar data collection
procedures as the previous two cohorts.
This Notice is specific to Phase 1. The
overall goal is to recruit child welfare
agencies in 83 primary sampling units
nationwide. Child welfare agencies will
be selected with probability
proportional to size, based on the
current distributions in the child
welfare system. Child welfare agency
recruitment will include: mail, email,
phone calls, and site visits with child
welfare agency administrators.
Respondents: Child welfare agency
administrators and other personnel.
Data collection will take place over a 2year period.
ANNUAL BURDEN ESTIMATES
Total number
of respondents
Instrument
Information package for agency administrators ..................
Initial call with agency staff ..................................................
In-person visit with agency staff ..........................................
Visit or call with agency staff explaining the sample file
process .............................................................................
Agency staff monthly sample file generation and transmission .............................................................................
Estimated Total Annual Burden
Hours: 795.
Additional Information: Copies of the
proposed collection may be obtained by
writing to the Administration for
Children and Families, Office of
Planning, Research and Evaluation, 330
C Street, SW., Washington, DC 20201,
Attn: OPRE Reports Clearance Officer.
All requests should be identified by the
title of the information collection. Email
address: OPREinfocollection@
acf.hhs.gov.
OMB Comment: OMB is required to
make a decision concerning the
collection of information between 30
and 60 days after publication of this
document in the Federal Register.
Therefore, a comment is best assured of
having its full effect if OMB receives it
within 30 days of publication. Written
comments and recommendations for the
proposed information collection should
be sent directly to the following: Office
of Management and Budget, Paperwork
Reduction Project, Email: OIRA_
SUBMISSION@OMB.EOP.GOV, Attn:
Desk Officer for the Administration for
Children and Families.
Robert Sargis,
ACF Certifying Officer.
[FR Doc. 2016–13682 Filed 6–9–16; 8:45 am]
asabaliauskas on DSK3SPTVN1PROD with NOTICES
BILLING CODE 4184–01–P
Annual
number of
respondents
1
1
1
0.25
1
1
14
57
10
83
42
1
2
84
83
42
15
1
630
[Docket No. FDA–2016–N–0001]
Arthritis Advisory Committee; Notice
of Meeting
Food and Drug Administration,
HHS.
Notice.
The Food and Drug
Administration (FDA) announces a
forthcoming public advisory committee
meeting of the Arthritis Advisory
Committee. The general function of the
committee is to provide advice and
recommendations to the Agency on
FDA’s regulatory issues. The meeting
will be open to the public.
DATES: The meeting will be held on July
13, 2016, from 7:30 a.m. to 5 p.m.
ADDRESSES: FDA White Oak Campus,
10903 New Hampshire Ave., Bldg. 31,
Conference Center, the Great Room (Rm.
1503), Silver Spring, MD 20993–0002.
Answers to commonly asked questions
including information regarding special
accommodations due to a disability,
visitor parking, and transportation may
be accessed at: https://www.fda.gov/
AdvisoryCommittees/
AboutAdvisoryCommittees/
ucm408555.htm.
SUMMARY:
FOR FURTHER INFORMATION CONTACT:
Moon Hee Choi, Center for Drug
Evaluation and Research, Food and
Drug Administration, 10903 New
Hampshire Ave., Bldg. 31, Rm. 2417,
Silver Spring, MD 20993–0002, 301–
796–9001, FAX: 301–847–8533, AAC@
fda.hhs.gov, or FDA Advisory
Committee Information Line, 1–800–
VerDate Sep<11>2014
19:02 Jun 09, 2016
Jkt 238001
PO 00000
Annual burden
hours
57
57
10
Food and Drug Administration
ACTION:
Average
burden hours
per response
114
114
20
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
AGENCY:
Number of
responses per
respondent
Frm 00036
Fmt 4703
Sfmt 4703
741–8138 (301–443–0572 in the
Washington, DC area). A notice in the
Federal Register about last minute
modifications that impact a previously
announced advisory committee meeting
cannot always be published quickly
enough to provide timely notice.
Therefore, you should always check the
Agency’s Web site at https://
www.fda.gov/AdvisoryCommittees/
default.htm and scroll down to the
appropriate advisory committee meeting
link, or call the advisory committee
information line to learn about possible
modifications before coming to the
meeting.
SUPPLEMENTARY INFORMATION:
Agenda: The committee will discuss
biologics license application 761042, for
GP2015, a proposed biosimilar to
Amgen Inc.’s ENBREL (etanercept)
submitted by Sandoz, Inc. The proposed
indications (uses) for this product are:
(1) Reducing signs and symptoms,
inducing major clinical response,
inhibiting the progression of structural
damage, and improving physical
function in patients with moderately to
severely active rheumatoid arthritis (in
combination with methotrexate (MTX)
or used alone); (2) reducing signs and
symptoms of moderately to severely
active polyarticular juvenile idiopathic
arthritis in patients ages 2 and older; (3)
reducing signs and symptoms,
inhibiting the progression of structural
damage of active arthritis, and
improving physical function in patients
with psoriatic arthritis (in combination
with MTX in patients who do not
respond adequately to MTX alone); (4)
reducing signs and symptoms in
patients with active ankylosing
spondylitis; and (5) treatment of adult
patients (18 years or older) with chronic
E:\FR\FM\10JNN1.SGM
10JNN1
]]>Agencies
[Federal Register Volume 81, Number 112 (Friday, June 10, 2016)]
[Notices]
[Pages 37600-37601]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-13682]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Administration for Children and Families
Submission for OMB Review; Comment Request
Title: National Survey of Child and Adolescent Well-Being-Third
Cohort (NSCAW III): Agency Recruitment.
OMB No.: 0970-0202.
Description: The Administration for Children and Families (ACF)
within the U.S. Department of Health and Human Services (HHS) intends
to collect data on a third cohort of children and families for the
National Survey of Child and Adolescent Well-Being (NSCAW). NSCAW is
the only source of nationally representative, longitudinal, firsthand
information about the functioning and well-being, service needs, and
service utilization of children and families who come to the attention
of the child welfare system. The first two cohorts of NSCAW were
collected beginning in 1999 and 2008 and studied children who had been
the subject of investigation by Child Protective Services. Children
were sampled from child welfare agencies nationwide.
The proposed data collection plan for the third cohort of NSCAW
includes two phases: Phase 1 includes child
[[Page 37601]]
welfare agency recruitment and collection of files for sampling
children, and Phase 2 includes baseline data collection and an 18-month
follow-up data collection. The current data collection plan calls for
selecting a new cohort of 4,565 children and families and repeating
similar data collection procedures as the previous two cohorts. This
Notice is specific to Phase 1. The overall goal is to recruit child
welfare agencies in 83 primary sampling units nationwide. Child welfare
agencies will be selected with probability proportional to size, based
on the current distributions in the child welfare system. Child welfare
agency recruitment will include: mail, email, phone calls, and site
visits with child welfare agency administrators.
Respondents: Child welfare agency administrators and other
personnel. Data collection will take place over a 2-year period.
Annual Burden Estimates
----------------------------------------------------------------------------------------------------------------
Annual number Number of Average
Instrument Total number of responses per burden hours Annual burden
of respondents respondents respondent per response hours
----------------------------------------------------------------------------------------------------------------
Information package for agency 114 57 1 0.25 14
administrators.................
Initial call with agency staff.. 114 57 1 1 57
In-person visit with agency 20 10 1 1 10
staff..........................
Visit or call with agency staff 83 42 1 2 84
explaining the sample file
process........................
Agency staff monthly sample file 83 42 15 1 630
generation and transmission....
----------------------------------------------------------------------------------------------------------------
Estimated Total Annual Burden Hours: 795.
Additional Information: Copies of the proposed collection may be
obtained by writing to the Administration for Children and Families,
Office of Planning, Research and Evaluation, 330 C Street, SW.,
Washington, DC 20201, Attn: OPRE Reports Clearance Officer. All
requests should be identified by the title of the information
collection. Email address: OPREinfocollection@acf.hhs.gov.
OMB Comment: OMB is required to make a decision concerning the
collection of information between 30 and 60 days after publication of
this document in the Federal Register. Therefore, a comment is best
assured of having its full effect if OMB receives it within 30 days of
publication. Written comments and recommendations for the proposed
information collection should be sent directly to the following: Office
of Management and Budget, Paperwork Reduction Project, Email:
OIRA_SUBMISSION@OMB.EOP.GOV, Attn: Desk Officer for the Administration
for Children and Families.
Robert Sargis,
ACF Certifying Officer.
[FR Doc. 2016-13682 Filed 6-9-16; 8:45 am]
BILLING CODE 4184-01-P
